Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Baxter
Farmers Insurance
Citi
Deloitte
AstraZeneca
UBS
Covington
Accenture

Generated: May 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 087457

« Back to Dashboard

NDA 087457 describes SYNACORT, which is a drug marketed by Medicis and is included in three NDAs. Additional details are available on the SYNACORT profile page.

The generic ingredient in SYNACORT is hydrocortisone. There are sixty-four drug master file entries for this compound. Forty-seven suppliers are listed for this compound. Additional details are available on the hydrocortisone profile page.
Summary for 087457
Tradename:SYNACORT
Applicant:Medicis
Ingredient:hydrocortisone
Patents:0
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 087457

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:CREAM;TOPICALStrength2.5%
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Dow
Julphar
Accenture
Fish and Richardson
AstraZeneca
Healthtrust
Fuji
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.